Nova Eye Medical Limited (ASX:EYE)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
AlphaRET	190.00K	168.00K	364.00K	241.00K	306.00K
AlphaRET Growth	13.10%	-53.85%	51.04%	-21.24%	-74.44%
Glaucoma Surgical Devices	29.08M	23.16M	16.66M	13.14M	13.09M
Glaucoma Surgical Devices Growth	25.56%	38.99%	26.82%	0.37%	13.10%
Total	29.27M	23.33M	17.03M	13.38M	13.39M
Total Growth	25.47%	37.00%	27.26%	-0.12%	4.89%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
United States of America	22.88M	17.31M	9.84M	8.78M	9.04M
United States of America Growth	32.20%	75.98%	12.04%	-2.84%	8.84%
Europe	3.89M	3.94M	4.11M	3.60M	3.17M
Europe Growth	-1.37%	-4.14%	14.30%	13.51%	-5.63%
Asia Pacific	1.96M	1.77M	2.72M	736.00K	992.00K
Asia Pacific Growth	10.82%	-35.12%	269.84%	-25.81%	3.44%
Other	507.00K	284.00K	274.00K	192.00K	124.00K
Other Growth	78.52%	3.65%	42.71%	54.84%	-
Australia	35.00K	27.00K	84.00K	76.00K	75.00K
Australia Growth	29.63%	-67.86%	10.53%	1.33%	-3.85%
Total	29.27M	23.33M	17.03M	13.38M	13.39M
Total Growth	25.47%	37.00%	27.26%	-0.12%	4.89%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 25, 2026

Data Sources Report a data error